P Durrington

1.8k total citations · 1 hit paper
16 papers, 1.4k citations indexed

About

P Durrington is a scholar working on Surgery, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, P Durrington has authored 16 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 3 papers in Molecular Biology and 3 papers in Clinical Biochemistry. Recurrent topics in P Durrington's work include Lipoproteins and Cardiovascular Health (6 papers), Paraoxonase enzyme and polymorphisms (3 papers) and Health Promotion and Cardiovascular Prevention (3 papers). P Durrington is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Paraoxonase enzyme and polymorphisms (3 papers) and Health Promotion and Cardiovascular Prevention (3 papers). P Durrington collaborates with scholars based in United Kingdom and United States. P Durrington's co-authors include Caroline A. Abbott, Sharon Arrol, Helen M. Colhoun, Deepak Bhatnagar, Handrean Soran, R Cramb, Theresa M. Marteau, J Yarwood, Yih-Yih Kok and A L Kinmonth and has published in prestigious journals such as British Journal of Pharmacology, Atherosclerosis and Nephrology Dialysis Transplantation.

In The Last Decade

P Durrington

15 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

1993 689 citations Sharon Arrol, Caroline A. Abbott et al. Atherosclerosis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P Durrington United Kingdom	10	572	314	285	256	256	16	1.4k
M. Mackness United Kingdom	15	573 1.0×	241 0.8×	366 1.3×	103 0.4×	285 1.1×	17	1.3k
Peter Winocour United Kingdom	29	599 1.0×	693 2.2×	1.3k 4.6×	151 0.6×	189 0.7×	118	3.2k
Rafel Masià Spain	15	162 0.3×	207 0.7×	177 0.6×	189 0.7×	87 0.3×	24	1.1k
Tanja Weinbrenner Spain	15	161 0.3×	294 0.9×	126 0.4×	327 1.3×	88 0.3×	15	1.5k
Anusha Bhaskar India	10	137 0.2×	102 0.3×	1.2k 4.1×	254 1.0×	113 0.4×	22	1.9k
Sri Venkata Madhu India	18	208 0.4×	202 0.6×	584 2.0×	202 0.8×	50 0.2×	42	1.4k
Nataša Bogavac‐Stanojević Serbia	18	143 0.3×	280 0.9×	221 0.8×	85 0.3×	62 0.2×	107	1.3k
Sean M. Lynch United States	13	108 0.2×	173 0.6×	73 0.3×	173 0.7×	41 0.2×	20	1.8k
Angelyne Amos Australia	5	91 0.2×	225 0.7×	969 3.4×	145 0.6×	62 0.2×	7	1.8k
D. Gail McCarver United States	22	183 0.3×	108 0.3×	70 0.2×	129 0.5×	64 0.3×	30	2.0k

Countries citing papers authored by P Durrington

Since Specialization

Citations

This map shows the geographic impact of P Durrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Durrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Durrington more than expected).

Fields of papers citing papers by P Durrington

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Durrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Durrington. The network helps show where P Durrington may publish in the future.

Co-authorship network of co-authors of P Durrington

This figure shows the co-authorship network connecting the top 25 collaborators of P Durrington. A scholar is included among the top collaborators of P Durrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Durrington. P Durrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Reiner, Željko, Alberico L. Catapano, Guy De Backer, et al.. (2011). The european society of cardiology and the european atherosclerosis society (ESC/EAS) guidelines on the management of dyslipidemia. Revista Española de Cardiología. 64. 3 indexed citations

Ara, Roberta, Abdullah Pandor, Indra Tumur, et al.. (2008). Estimating the health benefits and costs associated with ezetimibe coadministered with statin therapy compared with higher dose statin monotherapy in patients with established cardiovascular disease: Results of a Markov model for UK costs using data registries. Clinical Therapeutics. 30(8). 1508–1523. 15 indexed citations

Bhatnagar, Deepak, Handrean Soran, & P Durrington. (2008). Hypercholesterolaemia and its management. BMJ. 337(aug21 1). a993–a993. 124 indexed citations

Charlton-Menys, Valentine, Livia Pisciotta, P Durrington, et al.. (2007). Molecular characterization of two patients with severe LCAT deficiency. Nephrology Dialysis Transplantation. 22(8). 2379–2382. 11 indexed citations

Neil, H. A. W., et al.. (2007). Estimated 10-year cardiovascular risk in a British population: Results of a national screening project. Atherosclerosis. 194(1). 281–281. 1 indexed citations

Povey, Andrew C., et al.. (2005). Paraoxonase polymorphisms and self-reported chronic ill-health in farmers dipping sheep. Occupational Medicine. 55(4). 282–286. 11 indexed citations

Raikou, Maria, Alistair McGuire, Helen M. Colhoun, et al.. (2005). Cost-effectiveness of atorvastatin (10mg) in patients with type 2 diabetes without coronary heart disease: CARDS trial analysis and extrapolation. Oxford University Research Archive (ORA) (University of Oxford). 48. 1 indexed citations

Colhoun, Helen M., et al.. (2004). Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial. ACC Current Journal Review. 13(11). 34–34. 144 indexed citations

Durrington, P, et al.. (2003). Squalene synthase inhibitors. British Journal of Pharmacology. 139(5). 881–882. 16 indexed citations

10.

Durrington, P. (1996). ANY QUESTIONS. BMJ. 313(7062). 921–921. 1 indexed citations

11.

Durrington, P, A L Kinmonth, Clair Le Boutillier, et al.. (1994). Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. Family Heart Study Group.. PubMed. 308(6924). 313–20. 86 indexed citations

12.

Wood, David, A L Kinmonth, J Yarwood, et al.. (1994). Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ. 308(6924). 313–320. 297 indexed citations

13.

Arrol, Sharon, et al.. (1993). Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 104(1-2). 129–135. 689 indexed citations breakdown →

14.

Kumar, Satyendra, et al.. (1993). The relationship between serum butyrylcolinesterase activity, hypertriglyceridaemiaand insuliln sensitivity in diabetes mellitus. 85. 1 indexed citations

15.

Short, C. E., P Durrington, Deepak Bhatnagar, et al.. (1991). Serum lipoprotein (a) (Lp(a)) levels in nephrotic syndrome (NS), CAPD patients and renal transplant (Tx) recipients. Atherosclerosis. 90(2-3). 225–225. 3 indexed citations

16.

Durrington, P & S A Cairns. (1982). Acute-pancreatitis: a complication of beta-blockade.. BMJ. 284(6321). 1016–1016. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact